Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Quest Diagnostics Incorporated (DGX) vs Mettler-Toledo International, Inc. (MTD)

Quest Diagnostics Incorporated and Mettler-Toledo International, Inc. are both Diagnostics & Research companies. Mettler-Toledo International, Inc. is the larger, with a market value of $30.4B against $26.2B — 1.2× the size. Quest Diagnostics Incorporated trades at the lower P/E: 24.8× against 33.9×. Quest Diagnostics Incorporated grew revenue faster over the last twelve months: 9.87% against 6.91%. Mettler-Toledo International, Inc. has the higher net margin (21.9% vs 9.15%) and the higher return on invested capital (35.4% vs 7.94%). Across the 22 metrics below, Quest Diagnostics Incorporated leads on 13 and Mettler-Toledo International, Inc. on 9.

Valuation

Metric DGX MTD Diagnostics & Research median
P/E 24.77 33.94 33.95
P/S 2.27 7.36 4.87
P/B 3.35 2,372.01 3.12
Price to free cash flow 19.45 35.21 34.02
EV/EBITDA 14.14 24.88 25.20
EV/Sales 2.70 7.86 5.66
Earnings yield 4.04% 2.95% (1.75%)
Free cash flow yield 5.14% 2.84% (0.13%)

Profitability

Metric DGX MTD Diagnostics & Research median
Gross margin 33.11% 60.26% 50.89%
Operating margin 14.10% 28.41% (8.57%)
Net margin 9.15% 21.91% (6.37%)
Free cash flow margin 11.67% 20.90% 0.00%
Return on equity 14.03% (736.36%) (2.92%)
Return on assets 6.43% 25.61% (6.71%)
Return on invested capital 7.94% 35.40% 0.00%

Growth

Metric DGX MTD Diagnostics & Research median
Revenue growth (TTM) 9.87% 6.91% 7.69%
EPS growth (last fiscal year) 13.78% 3.88% —
Revenue growth, 5-year CAGR 3.18% 5.47% 7.40%
Net income growth, 5-year CAGR (7.06%) 7.60% 0.00%

Health

Metric DGX MTD Diagnostics & Research median
Debt to equity 0.72 164.70 0.11
Current ratio 1.59 1.12 2.02
Net debt to EBITDA 2.47 1.68 0.78

Dividend

Metric DGX MTD Diagnostics & Research median
Dividend yield 2.30% — 0.70%
Payout ratio 0.29 0.00 0.00

Size

Metric DGX MTD Diagnostics & Research median
Market cap 26.19b 30.44b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack